HUP9702403A2 - Eljárás vírusellenes proteáz inhibitorok intermedierjeinek előállítására - Google Patents
Eljárás vírusellenes proteáz inhibitorok intermedierjeinek előállításáraInfo
- Publication number
- HUP9702403A2 HUP9702403A2 HU9702403A HUP9702403A HUP9702403A2 HU P9702403 A2 HUP9702403 A2 HU P9702403A2 HU 9702403 A HU9702403 A HU 9702403A HU P9702403 A HUP9702403 A HU P9702403A HU P9702403 A2 HUP9702403 A2 HU P9702403A2
- Authority
- HU
- Hungary
- Prior art keywords
- alkyl
- aralkyl
- aryl
- hydrogen
- amine intermediates
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title abstract 2
- 230000001177 retroviral effect Effects 0.000 title abstract 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000001412 amines Chemical class 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract 1
- BLGJHQMNSBYLEZ-UHFFFAOYSA-N 2-hydroxyethanesulfonamide Chemical class NS(=O)(=O)CCO BLGJHQMNSBYLEZ-UHFFFAOYSA-N 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 abstract 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 125000004475 heteroaralkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 238000007040 multi-step synthesis reaction Methods 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract 1
- 239000002461 renin inhibitor Substances 0.000 abstract 1
- 229940086526 renin-inhibitors Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/18—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with hydroxy groups and at least two amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/26—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Királis hidrőxi-etil-amin, hidrőxi-etil-karbamid vagy hidrőxi-etil-szűlfőnamid izősztereket tartalmazó retrővirális prőteáz és renininhibitőrők állíthatók elő többlépéses szintézisben, amelyben királisamin intermediert használnak. A találmány szerinti új eljárással akirális amin intermedierek enantiőmériai , diasztereőmériai éskémiailag tiszta állapőtban nagy mennyiségekben állíthatók elő. Atalálmány tárgyát képezik az amin intermedierek szerves savakkal vagyszervetlen savakkal képzett sói is. Az amin intermediereket az (I),(IB), (IC) és (ID) általánős képlet ábrázőlja, ahől R1 jelentése alkil-, aril-, ciklőalkil-, ciklőalkil-alkil- vagyaralkilcsőpőrt, ahől R9 jelentése hidrőgénatőm, alkil-, aril- vagyaralkilcsőpőrt. R3 jelentése hidrőgénatőm, alkil-, alkenil-, alkinil-, hidrőxi-alkil-,alkőxi-alkil-, ciklőalkil-, ciklőalkil-alkil-, heterőciklőalkil-,heterőaril-, heterőciklőalkil-alkil-, aril-, aralkil-, heterőaralkil-,aminő-alkil-, N-mőnő- vagy N,N-diszűbsztitált aminő-alkil-csőpőrt; P1 és P2 jelentése egymástól függetlenül hidrőgénatőm, acil-,aralkil-, szilil-, aralkőxi-karbőnil-, alkőxi-karbőnil-, alkil-karbőnil-, aralkil-karbőnil-, aril-karbőnil- vagy ciklőalkenil-alkil-csőpőrt, vagy P1 és P2 a közbezárt nitrőgénatőmmal együttheterőciklűsős gyűrűrendszert képez. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/376,340 US5831117A (en) | 1995-01-20 | 1995-01-20 | Method of preparing retroviral protease inhibitor intermediates |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9702403A2 true HUP9702403A2 (hu) | 1999-09-28 |
HUP9702403A3 HUP9702403A3 (en) | 1999-10-28 |
Family
ID=23484633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9702403A HUP9702403A3 (en) | 1995-01-20 | 1996-01-18 | Method of preparing retroviral protease inhibitor intermediates |
Country Status (16)
Country | Link |
---|---|
US (7) | US5831117A (hu) |
EP (1) | EP0804410B1 (hu) |
JP (1) | JP3978229B2 (hu) |
KR (1) | KR100385013B1 (hu) |
CN (1) | CN1623977A (hu) |
AT (1) | ATE204851T1 (hu) |
AU (1) | AU692062B2 (hu) |
BR (1) | BR9606981A (hu) |
CA (1) | CA2210973C (hu) |
DE (1) | DE69614824T2 (hu) |
DK (1) | DK0804410T3 (hu) |
ES (1) | ES2162650T3 (hu) |
HU (1) | HUP9702403A3 (hu) |
NZ (1) | NZ302072A (hu) |
PT (1) | PT804410E (hu) |
WO (1) | WO1996022275A1 (hu) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5831117A (en) * | 1995-01-20 | 1998-11-03 | G. D. Searle & Co. | Method of preparing retroviral protease inhibitor intermediates |
CA2401749A1 (en) * | 2000-03-23 | 2001-09-27 | Elan Pharmaceuticals, Inc. | Compounds and methods to treat alzheimer's disease |
US6992081B2 (en) | 2000-03-23 | 2006-01-31 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
US6846813B2 (en) * | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
US20030096864A1 (en) * | 2000-06-30 | 2003-05-22 | Fang Lawrence Y. | Compounds to treat alzheimer's disease |
ATE314343T1 (de) | 2000-06-30 | 2006-01-15 | Elan Pharm Inc | Verbindungen zur behandlung der alzheimerischen krankheit |
US6982264B2 (en) | 2001-06-27 | 2006-01-03 | Elan Pharmaceuticals, Inc. | Substituted alcohols useful in treatment of Alzheimer's disease |
US20070213407A1 (en) * | 2001-06-29 | 2007-09-13 | Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc | Compounds to treat Alzheimer's disease |
US6867302B2 (en) * | 2001-07-13 | 2005-03-15 | Board Of Trustees Of Michigan State University | Process for the catalytic synthesis of biaryls and polymers from aryl compounds |
WO2004043916A1 (en) | 2002-11-12 | 2004-05-27 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
AR057182A1 (es) | 2005-11-28 | 2007-11-21 | Tibotec Pharm Ltd | Compuestos de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih |
EP2292594A4 (en) * | 2008-05-19 | 2014-10-15 | Kyorin Seiyaku Kk | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINOALCOOL DERIVATIVE |
CN116675613B (zh) * | 2023-08-03 | 2023-10-10 | 北京元延医药科技股份有限公司 | 手性拆分制备重酒石酸去甲肾上腺素的方法 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4268688A (en) | 1973-02-16 | 1981-05-19 | Monsanto Company | Asymmetric hydroformylation process |
JPS5825677B2 (ja) | 1977-09-26 | 1983-05-28 | 武田薬品工業株式会社 | 3−テトラゾ−ル−1−アザキサントン誘導体およびその製造法 |
US5142056A (en) | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US4477414A (en) | 1981-05-20 | 1984-10-16 | Fumakilla Limited | Evaporative container |
EP0068378B1 (en) * | 1981-06-26 | 1986-03-05 | Schering Corporation | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
EP0104041B1 (en) | 1982-09-15 | 1988-07-27 | Aktiebolaget Hässle | Enzyme inhibitors |
US4668770A (en) | 1982-12-27 | 1987-05-26 | Merck & Co., Inc. | Renin inhibitory tripeptides |
WO1984003044A1 (en) | 1983-02-07 | 1984-08-16 | Ferring Ab | Enzyme inhibitors |
JPS59227851A (ja) | 1983-06-09 | 1984-12-21 | Sankyo Co Ltd | レニン阻害作用を有するペプチド類 |
US4514391A (en) | 1983-07-21 | 1985-04-30 | E. R. Squibb & Sons, Inc. | Hydroxy substituted peptide compounds |
US4477441A (en) | 1983-09-14 | 1984-10-16 | Merck & Co., Inc. | Renin inhibitors containing a C-terminal disulfide cycle |
US4645759A (en) | 1984-06-22 | 1987-02-24 | Abbott Laboratories | Renin inhibiting compounds |
US4749792A (en) * | 1984-09-26 | 1988-06-07 | E. R. Squibb & Sons, Inc. | Diamino ketones and alcohols as analgesic agents |
US4616088A (en) | 1984-10-29 | 1986-10-07 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitor |
CN1003504B (zh) | 1984-12-03 | 1989-03-08 | 三井东圧化学有限公司 | 氯气制备方法 |
US4826815A (en) * | 1985-05-17 | 1989-05-02 | Abbott Laboratories | Renin inhibiting compounds |
US4668769A (en) | 1985-08-02 | 1987-05-26 | Hoover Dennis J | Oxa- and azahomocyclostatine polypeptides |
US4599198A (en) | 1985-08-02 | 1986-07-08 | Pfizer Inc. | Intermediates in polypeptide synthesis |
CA1282549C (en) | 1985-11-12 | 1991-04-02 | Eric M. Gordon | Aminocarbonyl renin inhibitors |
US4757050A (en) | 1985-12-23 | 1988-07-12 | E. R. Squibb Sons, Inc. | Ureido renin inhibitors |
CA1297631C (en) | 1985-12-23 | 1992-03-17 | Sesha I. Natarajan | Ureido renin inhibitors |
US4857507A (en) * | 1986-04-11 | 1989-08-15 | Abbott Laboratories | Angiotensinogen analogs |
US4880938A (en) * | 1986-06-16 | 1989-11-14 | Merck & Co., Inc. | Amino acid analogs |
DE3635907A1 (de) | 1986-10-22 | 1988-04-28 | Merck Patent Gmbh | Hydroxy-aminosaeurederivate |
GB2200115B (en) * | 1987-01-21 | 1990-11-14 | Sandoz Ltd | Novel peptide derivatives, their production and use |
DE3800591A1 (de) | 1987-01-21 | 1988-08-04 | Sandoz Ag | Neue peptidderivate, ihre herstellung und verwendung |
USH725H (en) | 1987-02-26 | 1990-01-02 | E. R. Squibb & Sons, Inc. | Ureido amino and imino acids, compositions and methods for use |
GB8707412D0 (en) | 1987-03-27 | 1987-04-29 | Fujisawa Pharmaceutical Co | Peptide compounds |
DE3711911A1 (de) | 1987-04-08 | 1988-10-20 | Bayer Ag | Optisch aktive (alpha)-aminoaldehyde, verfahren zu ihrer herstellung und ihre verwendung zur stereoselektiven herstellung optisch aktiver ss-aminoalkohole |
DE3830825A1 (de) | 1987-09-15 | 1989-03-23 | Sandoz Ag | Hydrophile reninhemmer, ihre herstellung und verwendung |
DE3800059A1 (de) * | 1988-01-04 | 1989-07-13 | Paul Merkle | Modulo-10-zaehler fuer beide zaehl-richtungen |
IL89900A0 (en) | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
US4977277A (en) | 1988-05-09 | 1990-12-11 | Abbott Laboratories | Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof |
IL90218A0 (en) | 1988-05-13 | 1989-12-15 | Abbott Lab | Retroviral protease inhibitors |
CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
IL91307A0 (en) | 1988-08-24 | 1990-03-19 | Merck & Co Inc | Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them |
CA2012306A1 (en) | 1989-03-28 | 1990-09-28 | Werner Neidhart | Amino acid derivatives |
DE3912829A1 (de) | 1989-04-19 | 1990-10-25 | Bayer Ag | Verwendung von renininhibitorischen peptiden als mittel gegen retroviren |
TW225540B (hu) | 1990-06-28 | 1994-06-21 | Shionogi & Co | |
EP0538366A1 (en) | 1990-07-06 | 1993-04-28 | Smithkline Beecham Corporation | Retroviral protease inhibitors |
EP0558630B1 (en) * | 1990-11-19 | 1998-04-08 | Monsanto Company | Retroviral protease inhibitors |
AU4253193A (en) | 1992-05-20 | 1993-12-13 | G.D. Searle & Co. | Urea-containing hydroxyethylamine compounds as retroviral protease inhibitors |
ATE218541T1 (de) * | 1992-08-25 | 2002-06-15 | Searle & Co | Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen |
IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
ES2061380B1 (es) | 1992-11-23 | 1995-07-01 | Boehringer Ingelheim Espana | Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores. |
US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US5514801A (en) * | 1992-12-29 | 1996-05-07 | Monsanto Company | Cyclic sulfone containing retroviral protease inhibitors |
ES2125077T3 (es) * | 1993-07-15 | 1999-02-16 | Hoffmann La Roche | Procedimiento de obtencion de una n-tert-butilamida. |
ATE191907T1 (de) * | 1993-11-23 | 2000-05-15 | Searle & Co | Verfahren zur herstellung von zwischenprodukten, die für die herstellung von retroviral-protease hemmenden verbindungen verwendbar sind |
JP2996459B2 (ja) * | 1994-07-14 | 1999-12-27 | ダイワ精工株式会社 | ゴルフクラブヘッド |
US5831117A (en) | 1995-01-20 | 1998-11-03 | G. D. Searle & Co. | Method of preparing retroviral protease inhibitor intermediates |
EP1236459B1 (en) * | 2000-07-19 | 2005-11-23 | Tokuyama Corporation | Photo-curable reparative material for dental use |
US20040162679A1 (en) | 2002-05-03 | 2004-08-19 | Linheng Li | Method for predicting gene potential and cell commitment |
-
1995
- 1995-01-20 US US08/376,340 patent/US5831117A/en not_active Expired - Fee Related
-
1996
- 1996-01-18 KR KR1019970704936A patent/KR100385013B1/ko not_active IP Right Cessation
- 1996-01-18 CA CA002210973A patent/CA2210973C/en not_active Expired - Fee Related
- 1996-01-18 EP EP96903641A patent/EP0804410B1/en not_active Expired - Lifetime
- 1996-01-18 AT AT96903641T patent/ATE204851T1/de not_active IP Right Cessation
- 1996-01-18 PT PT96903641T patent/PT804410E/pt unknown
- 1996-01-18 AU AU47653/96A patent/AU692062B2/en not_active Ceased
- 1996-01-18 HU HU9702403A patent/HUP9702403A3/hu active IP Right Revival
- 1996-01-18 DE DE69614824T patent/DE69614824T2/de not_active Expired - Fee Related
- 1996-01-18 WO PCT/US1996/000918 patent/WO1996022275A1/en active IP Right Grant
- 1996-01-18 NZ NZ302072A patent/NZ302072A/xx unknown
- 1996-01-18 CN CNA2004100560283A patent/CN1623977A/zh active Pending
- 1996-01-18 DK DK96903641T patent/DK0804410T3/da active
- 1996-01-18 ES ES96903641T patent/ES2162650T3/es not_active Expired - Lifetime
- 1996-01-18 JP JP52244296A patent/JP3978229B2/ja not_active Expired - Lifetime
- 1996-01-18 BR BR9606981A patent/BR9606981A/pt not_active IP Right Cessation
-
1998
- 1998-02-17 US US09/024,662 patent/US6201150B1/en not_active Expired - Fee Related
-
2000
- 2000-12-21 US US09/741,087 patent/US6515162B2/en not_active Expired - Fee Related
-
2002
- 2002-12-23 US US10/325,952 patent/US6849760B2/en not_active Expired - Fee Related
-
2004
- 2004-10-12 US US10/961,405 patent/US7060851B2/en not_active Expired - Fee Related
-
2006
- 2006-05-16 US US11/434,509 patent/US20060270855A1/en not_active Abandoned
- 2006-07-05 US US11/480,586 patent/US20070015818A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2210973C (en) | 2007-08-07 |
EP0804410A1 (en) | 1997-11-05 |
DE69614824D1 (de) | 2001-10-04 |
ATE204851T1 (de) | 2001-09-15 |
US20010047111A1 (en) | 2001-11-29 |
KR100385013B1 (ko) | 2003-08-19 |
EP0804410B1 (en) | 2001-08-29 |
US20050131075A1 (en) | 2005-06-16 |
BR9606981A (pt) | 1997-11-04 |
AU4765396A (en) | 1996-08-07 |
US6515162B2 (en) | 2003-02-04 |
KR19980701545A (ko) | 1998-05-15 |
PT804410E (pt) | 2002-01-30 |
CN1623977A (zh) | 2005-06-08 |
WO1996022275A1 (en) | 1996-07-25 |
DK0804410T3 (da) | 2001-11-26 |
JPH10512571A (ja) | 1998-12-02 |
CA2210973A1 (en) | 1996-07-25 |
ES2162650T3 (es) | 2002-01-01 |
DE69614824T2 (de) | 2002-04-11 |
US20030171612A1 (en) | 2003-09-11 |
AU692062B2 (en) | 1998-05-28 |
JP3978229B2 (ja) | 2007-09-19 |
NZ302072A (en) | 1999-01-28 |
US5831117A (en) | 1998-11-03 |
US7060851B2 (en) | 2006-06-13 |
US6201150B1 (en) | 2001-03-13 |
US20060270855A1 (en) | 2006-11-30 |
US20070015818A1 (en) | 2007-01-18 |
US6849760B2 (en) | 2005-02-01 |
HUP9702403A3 (en) | 1999-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9702403A2 (hu) | Eljárás vírusellenes proteáz inhibitorok intermedierjeinek előállítására | |
HUP0400321A2 (hu) | Fluorpirrolidin-származékok mint dipeptidil-dipeptidáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
FR2696464B1 (fr) | Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III. | |
CO4950618A1 (es) | Inhibidores de proteasas | |
AP2003002841A0 (en) | Quinazolines as MMP-13 inhibitors | |
DE69722027D1 (de) | Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung | |
HUP0203521A2 (hu) | Kristályos 4-karboxi-amino-2-etil-1,2,3,4-tetrahidro-kinolin CEPT inhibitor, eljárás az előállítására, ezt tartalmazó gyógyszerkészítmény és alkalmazása | |
EP1595870A4 (en) | PROCESS FOR PRODUCING A PHENYLALANINE DERIVATIVE HAVING A QUINAZOLINEDIONE SKELETON AND INTERMEDIATE THEREOF | |
MXPA04008681A (es) | Compuestos oxo-azabiciclicos. | |
NZ336623A (en) | 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines for use in the treatment and prevention of disorders of the central nervous system | |
AR045768A1 (es) | Compuestos de cefem y sus sales farmaceuticamente aceptables | |
DE60226038D1 (de) | Verfahren zur synthese von aminen wie ephedrin und zwischenprodukten | |
MXPA03000547A (es) | Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares. | |
CA2281918A1 (en) | Oxazolidines as 5-ht2a-antagonists | |
HUP0004588A2 (hu) | Szubsztituált 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-ol-származékok, eljárás előállításukra és alkalmazásuk gyógyszerként, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0104193A2 (hu) | Javított eljárás új antidiabetikus hatású vegyületek előállítására | |
PE20011374A1 (es) | 4-amino-azepan-3-ona como inhibidores de proteasas | |
AP1417A (en) | Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindopril. | |
ATE309187T1 (de) | Verfahren zur reinigung von abgasströmen | |
HUP0105116A2 (hu) | 2,3-0-Izopropilidén-monoszacharid-származékok, mint sejtadhézió-gátlók és az ezeket tartalmazó gyógyászati készítmények, eljárás a vegyületek előállítására | |
HK1053301A1 (en) | Novel method for synthesis of N-Ä(s)-1-carboxybutylÜ-(s)-alanine esters and use in synthesis of perindopril. | |
DK1347965T3 (da) | Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf | |
ATE238292T1 (de) | Verfahren zu synthese von n-(mercaptoacyl)- aminosäure derivaten von alfasubstituierte acrylsäuren an | |
BR0107822A (pt) | Processo para a obtenção de ácido fórmico anidro ou substancialmente anidro, uso de uma carboxamida, e, aparelho para realizar um processo | |
HUP0001976A1 (hu) | Vírusellenes hatású proteáz inhibitorok, valamint ezeket tartalmazó gyógyászati készítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NF4A | Restoration of patent protection | ||
FD9A | Lapse of provisional protection due to non-payment of fees |